Case 297: Mucinous Adenocarcinoma of the Prostate

Radiology ◽  
2022 ◽  
Vol 302 (1) ◽  
pp. 238-242
Author(s):  
Alexandre Fligelman Kanas ◽  
Sandro Santos Fenelon ◽  
João Manoel Miranda Magalhães Santos ◽  
Rafael Ferreira Coelho ◽  
Giuliano Betoni Guglielmetti ◽  
...  
1990 ◽  
Vol 94 (5) ◽  
pp. 641-645 ◽  
Author(s):  
Dong W. Lee ◽  
Jae Y. Ro ◽  
Aysegul A. Sahin ◽  
Jin S. Lee ◽  
Alberto G. Ayala

1990 ◽  
Vol 21 (6) ◽  
pp. 593-600 ◽  
Author(s):  
Jae Y. Ro ◽  
David J. Grignon ◽  
Alberto G. Ayala ◽  
Pedro L. Fernandez ◽  
Nelson G. Ordonez ◽  
...  

2020 ◽  
Author(s):  
Jiakun Li ◽  
Shi Qiu ◽  
Xi-nan Cui ◽  
Kun Jin ◽  
Xiaonan Zheng ◽  
...  

Abstract Background: Few studies on predicting survival in patients with histology of mucinous adenocarcinoma of the prostate have been done.Objective: Nomogram is a mathematical model in which various important factors are combined to predict a specific end point. The purpose of this study was to evaluate the prognostic value of clinical factors in patients with mucinous adenocarcinoma and to construct nomogram to predict the survival rate. Design,Setting,and Participants: A nomogram was designed to predict the survival rate of 356 patients with invasive ductal carcinoma selected from the surveillance, epidemiology and final results (SEER) database. Univariate and multivariate models of the cohort were done firstly.And then a model of nomogram that included age, race, grade, stage M and chemotherapy were constructed to predict the 3-year and 5-year survival of prostate cancer patients with histology of mucinous adenocarcinoma. Based on different time, we designed two nomograms.Results and limitations: After the discrimination and calibration, C-index was 0.8138. The specificity was 86.12%, sensitivity was 55.89% for 3-year nomogram . Its survival was 91.49% and AUC was 0.7467. The specificity was 82.42%, sensitivity was 54.83% for 5-year nomogram. Its Survival was 86.73% and AUC was 0.7555. Respectively, which indicated relative good discrimination of the nomogram. Conclusions: This clinical model shows a high ability to predict the survival rate of mucinous adenocarcinoma patients with histologically prostate cancer, making this model a novel and attractive model for predicting the survival rate of patients.


2014 ◽  
Vol 2014 ◽  
pp. 1-3 ◽  
Author(s):  
Christos Kalaitzis ◽  
Michael Koukourakis ◽  
Stilianos Giannakopoulos ◽  
Alexandra Giatromanolaki ◽  
Efthimios Sivridis ◽  
...  

Introduction. Mucinous adenocarcinoma of the prostate is a rare variant of prostate cancer. Its malignant potential and the clinical course of the affected patients remain, by and large, controversial. No data exist about the course of metastatic mucinous adenocarcinoma of the prostate.Case Presentation. This case report describes the excellent clinical course of a 68-year-old patient with metastatic mucinous adenocarcinoma of the prostate, treated by radical prostatectomy, irradiation, and androgen deprivation.Conclusion. In our case, mucinous adenocarcinoma of the prostate does not appear to behave differently than acinar prostate cancer. Its malignant potential is dependent on its Gleason score.


2001 ◽  
Vol 165 (3) ◽  
pp. 912-913 ◽  
Author(s):  
BERND WULLICH ◽  
VOLKER ROHDE ◽  
VOLKER MOLL ◽  
RAMONA LENSCH ◽  
MARGITTA RETZ ◽  
...  

1986 ◽  
Vol 17 (8) ◽  
pp. 863-865 ◽  
Author(s):  
Daniel G. Odom ◽  
Craig F. Donatucci ◽  
George E. Deshon

1994 ◽  
Vol 151 (3) ◽  
pp. 701-702 ◽  
Author(s):  
Joel M.H. Teichman ◽  
Ahmed Shabaik ◽  
Alan M. Demby

2009 ◽  
Vol 193 (3) ◽  
pp. W238-W243 ◽  
Author(s):  
Antonio C. Westphalen ◽  
Fergus V. Coakley ◽  
John Kurhanewicz ◽  
Galen Reed ◽  
Zhen J. Wang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document